385 related articles for article (PubMed ID: 9501051)
1. Differential behavior of the Mo + PyF101 enhancer variant of Moloney murine leukemia virus in rats and mice.
Brightman BK; Okimoto M; Kulkarni V; Lander JK; Fan H
Virology; 1998 Mar; 242(1):60-7. PubMed ID: 9501051
[TBL] [Abstract][Full Text] [Related]
2. Appearance of mink cell focus-inducing recombinants during in vivo infection by moloney murine leukemia virus (M-MuLV) or the Mo+PyF101 M-MuLV enhancer variant: implications for sites of generation and roles in leukemogenesis.
Lander JK; Chesebro B; Fan H
J Virol; 1999 Jul; 73(7):5671-80. PubMed ID: 10364317
[TBL] [Abstract][Full Text] [Related]
3. An enhancer variant of Moloney murine leukemia virus defective in leukemogenesis does not generate detectable mink cell focus-inducing virus in vivo.
Brightman BK; Rein A; Trepp DJ; Fan H
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2264-8. PubMed ID: 2006167
[TBL] [Abstract][Full Text] [Related]
4. Recombinant mink cell focus-inducing virus and long terminal repeat alterations accompany the increased leukemogenicity of the Mo+PyF101 variant of Moloney murine leukemia virus after intraperitoneal inoculation.
Belli B; Patel A; Fan H
J Virol; 1995 Feb; 69(2):1037-43. PubMed ID: 7815481
[TBL] [Abstract][Full Text] [Related]
5. Escape from in vivo restriction of Moloney mink cell focus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations.
Brightman BK; Farmer C; Fan H
J Virol; 1993 Dec; 67(12):7140-8. PubMed ID: 8230436
[TBL] [Abstract][Full Text] [Related]
6. Effects of nonleukemogenic and wild-type Moloney murine leukemia virus on lymphoid cells in vivo: identification of a preleukemic shift in thymocyte subpopulations.
Davis BR; Chandy KG; Brightman BK; Gupta S; Fan H
J Virol; 1986 Nov; 60(2):423-30. PubMed ID: 3490580
[TBL] [Abstract][Full Text] [Related]
7. The leukemogenic potential of an enhancer variant of Moloney murine leukemia virus varies with the route of inoculation.
Belli B; Fan H
J Virol; 1994 Nov; 68(11):6883-9. PubMed ID: 7933068
[TBL] [Abstract][Full Text] [Related]
8. A model for mixed virus disease: co-infection with Moloney murine leukemia virus potentiates runting induced by polyomavirus (A2 strain) in Balb/c and NIH Swiss mice.
Atencio IA; Belli B; Hobbs M; Cheng SF; Villarreal LP; Fan H
Virology; 1995 Oct; 212(2):356-66. PubMed ID: 7571405
[TBL] [Abstract][Full Text] [Related]
9. Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro.
Fan H; Mittal S; Chute H; Chao E; Pattengale PK
J Virol; 1986 Oct; 60(1):204-14. PubMed ID: 3747027
[TBL] [Abstract][Full Text] [Related]
10. Leukemogenicity of Moloney murine leukemia viruses carrying polyoma enhancer sequences in the long terminal repeat is dependent on the nature of the inserted polyoma sequences.
Fan H; Chute H; Chao E; Pattengale PK
Virology; 1988 Sep; 166(1):58-65. PubMed ID: 2842957
[TBL] [Abstract][Full Text] [Related]
11. Moloney murine leukemia virus-induced preleukemic thymic atrophy and enhanced thymocyte apoptosis correlate with disease pathogenicity.
Bonzon C; Fan H
J Virol; 1999 Mar; 73(3):2434-41. PubMed ID: 9971828
[TBL] [Abstract][Full Text] [Related]
12. Moloney murine leukemia virus infects cells of the developing hair follicle after neonatal subcutaneous inoculation in mice.
Okimoto MA; Fan H
J Virol; 1999 Mar; 73(3):2509-16. PubMed ID: 9971836
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow depletion by 89Sr complements a preleukemic defect in a long terminal repeat variant of Moloney murine leukemia virus.
Li QX; Fan H
J Virol; 1991 Aug; 65(8):4442-8. PubMed ID: 1649340
[TBL] [Abstract][Full Text] [Related]
14. Preleukemic hematopoietic hyperplasia induced by Moloney murine leukemia virus is an indirect consequence of viral infection.
Brightman BK; Davis BR; Fan H
J Virol; 1990 Sep; 64(9):4582-4. PubMed ID: 2200891
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
Nazarov V; Hilbert D; Wolff L
Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
[TBL] [Abstract][Full Text] [Related]
16. Leukaemogenesis by the delta Mo + SV Moloney murine leukaemia virus (M-MuLV) variant in E mu pim-1 transgenic mice: high frequency of recombination with a solo endogenous M-MuLV LTR in vivo.
Suchman EL; Pattengale PK; Fan H
J Gen Virol; 1995 Feb; 76 ( Pt 2)():347-56. PubMed ID: 7844555
[TBL] [Abstract][Full Text] [Related]
17. Effects of murine leukemia virus infection on long-term hematopoiesis in vitro emphasized by increased survival of bone marrow cultures derived from BALB/Mo mice.
Greenberger JS; Shadduck RK; Jaenisch R; Waheed A; Sakakeeny MA
Cancer Res; 1981 Sep; 41(9 Pt 1):3556-65. PubMed ID: 6266658
[TBL] [Abstract][Full Text] [Related]
18. Chimeras between SRS and Moloney murine leukemia viruses reveal novel determinants in disease specificity and MCF recombinant formation.
Jahid S; Bundy LM; Granger SW; Fan H
Virology; 2006 Jul; 351(1):7-17. PubMed ID: 16616947
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a preleukemic state induced by Moloney murine leukemia virus: evidence for two infection events during leukemogenesis.
Davis BR; Brightman BK; Chandy KG; Fan H
Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4875-9. PubMed ID: 3474632
[TBL] [Abstract][Full Text] [Related]
20. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
